---
layout: post
title: "Revocation of Emergency Use of Three Biological Products; Availability"
date: 2026-02-04 21:45:56 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-19272
original_published: 2025-10-02 00:00:00 +0000
significance: 8.00
---

# Revocation of Emergency Use of Three Biological Products; Availability

**Published:** February 04, 2026 21:45 UTC
**Source:** Federal Register
**Original Published:** October 02, 2025 00:00 UTC
**Document Number:** 2025-19272

## Summary

The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorizations (EUA) (the Authorizations) issued to Pfizer, Inc. for Pfizer-BioNTech COVID-19 Vaccine; to ModernaTX, Inc. for Moderna COVID-19 Vaccine; and to Novavax, Inc. for Novavax COVID-19 Vaccine, Adjuvanted. FDA revoked these Authorizations under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocations, which include an explanation of the reasons for each revocation, are reprinted in this document.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/10/02/2025-19272/revocation-of-emergency-use-of-three-biological-products-availability)
- API: https://www.federalregister.gov/api/v1/documents/2025-19272

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
